Literature DB >> 20175968

Predicting response to pegylated interferon/ribavirin-based therapy in genotype 1 chronic hepatitis C patients: results of 3 independent genome-wide association studies.

Sumeet K Asrani1, W Ray Kim.   

Abstract

Entities:  

Year:  2010        PMID： 20175968     DOI： 10.1053/j.gastro.2010.02.023

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  The future developments in hepatology: no need for a jaundiced view.

Authors:  Ahmed Mohamed Elsharkawy; Mark Hudson
Journal:  Frontline Gastroenterol       Date:  2012-05-31

2.  Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making.

Authors:  Col Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2011-08-26

3.  No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.

Authors:  Nae-Yun Heo; Young-Suk Lim; Woochang Lee; Minkyung Oh; Jiyun An; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Han Chu Lee; Yung Sang Lee; Dong Jin Suh
Journal:  Clin Mol Hepatol       Date:  2014-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.